You have no items in your shopping cart.
On Promotion
Tested Applications
Conjugation
Featured Product
Search results for: 'Cov'
84.50%
63.84 kDa (predicted)
100 μg, 200 μg, 500 μg98.00%
47.5 kDa (predicted); 47.1 kDa (reducing conditions)
100 μg94.00%
46.51 kDa (predicted)
100 μg, 200 μg, 500 μg93.30%
79.9 kDa (predicted); 94 kDa (reducing condition, due to glycosylation)
100 μg, 200 μg, 500 μgGreater than 95% as determined by reducing SDS-PAGE.
52.1kDa; 58-65kDa, reducing conditions
HEK293 cells
0.05 mgGreater than 95% as determined by reducing SDS-PAGE.
26kDa; 33-36 kDa, reducing conditions
HEK293 cells
0.05 mgGreater than 95% as determined by reducing SDS-PAGE.
17.3kDa, 28-50kDa
Mammalian Cells
0.05 mgGreater than 95% as determined by reducing SDS-PAGE.
32.4kDa, 40-70kDa
Mammalian Cells
0.05 mgGreater than 95% as determined by reducing SDS-PAGE.
101.3kDa, 130-160kDa
Mammalian Cells
0.05 mg
SARS-CoV-1 Pseudovirus [orb1227399]NeA